Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs their popularity will slow down anytime soon, especially with the prospect of a daily pill form on the horizon.

With weight-loss injectables now being sold at Costco and other major retailers, drugs like Ozempic are becoming more mainstream and accessible to the public. However, if you’re new to the world of GLP-1 medications or are thinking about switching prescriptions due to side effects,

Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more rapid weight loss than its popular obesity injection Wegovy.